Kymera Therapeutics
KYMR
#3656
Rank
C$4.07 B
Marketcap
$62.88
Share price
3.38%
Change (1 day)
130.16%
Change (1 year)

Kymera Therapeutics (KYMR) - Cash on Hand

Cash on Hand as of September 2024 : C$0.76 Billion

According to Kymera Therapeutics's latest financial reports the company has C$0.76 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Kymera Therapeutics - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$0.49 B-10.01%
2022-12-31C$0.55 B-2.01%
2021-12-31C$0.56 B49.29%
2020-12-31C$0.37 B214.47%
2019-12-31C$0.12 B113.69%
2018-12-31C$56.2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.40 B-47.92%๐Ÿ‡บ๐Ÿ‡ธ USA